12P Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
Titel:
12P Gene expression profiling in early breast cancer treated with neoadjuvant ribociclib plus letrozole (R+L) versus chemotherapy (CT): A correlative analysis of the SOLTI-1402/CORALLEEN phase II trial
Auteur:
Chic, N. González-Farré, B. Paré, L. Pascual, T. Saura, C. Hernando Melia, C. Muñoz, M. Fernandez, P. Martínez, D. Sanfeliu, E. Brasó-Maristany, F. González-Farré, X. Oliveira, M. Gil-Gil, M. Celiz, P. Ciruelos, E.M. Villagrasa, P. Gavila Gregori, J. Prat, A.